• This event has passed.

Fertility Options for Women: Improving Awareness, Access, and Outcomes

September 20, 2021 - September 21, 2021

Infertility in women can be caused by a variety of issues, some of which are easily identifiable and others which are not. It can be caused by damage to the uterus or fallopian tubes or problems with ovulation or the cervix. Challenges conceiving are also associated with anxiety and stress in either partner.

While there are several options available to attempt to treat infertility, including medicine, surgery, intrauterine insemination or assisted reproductive technology, factors like cost, invasiveness, and success rate can hinder access and create disparities in women’s reproductive health.

In September 2021, SWHR convened an interdisciplinary working group of health care providers, researchers, patients and patient advocates, and policy leaders for a closed two-day roundtable meeting to discuss how to eliminate barriers to access and reduce health disparities related to treatments for infertility in women.

+ Google Calendar+ Add to iCalendar

Details

Start:
September 20, 2021
End:
September 21, 2021
Event Categories:
, ,

Venue

Virtual Event

Organizer

SWHR

Roundtable Highlights

Facing Infertility: How a Shift in Approach, Education, and Policy Could Improve Outcomes
Infertility—defined as failure to conceive after 1 year of regular, unprotected sex—is increasingly common in the United States. For the more than 10% of couples that are affected by infertility, the physical, emotional, and financial challenges are exacerbated by high patient burden for self-education and advocacy, inconsistent residency training and provider education, and challenges related... Read more »

Objectives

The objectives of the roundtable are to:

  • Review the science and health care landscape and develop strategies to address knowledge gaps related to improving fertility and maternal health outcomes;
  • Explore the science and policies on the benefits of minimally invasive fertility options for women, including tubal flushing with hysterosalpingography (HSG);
  • Identify opportunities to leverage innovation and increase access to improve health equity and reduce disparities in maternal health; and
  • Develop materials to expand education and raise awareness about fertility options for women, health care providers, and policy stakeholders.

Roundtable Members

Kurt T. Barnhart, MD, MSCE, Associate Chief, Penn Fertility Care, Penn Medicine

William Burns, MD, FACOG, Associate Professor, Division of Reproductive Endocrinology, Marshall University

Barbara Collura, President and CEO, RESOLVE: The National Infertility Association

Kerri Cornish-Morton, Patient

Stacey L. Edwards-Dunn, MPH, MDIV, DMIN, Founder and President, Fertility for Colored Girls

Davina Fankhauser, Co-Founder & Executive Director, Fertility Within Reach

David Frankfurter, MD, Medical Director of IVF, The Fertility & IVF Center, Professor of Obstetrics & Gynecology, George Washington University

Tarun Jain, MD, Associate Professor and Medical Director, Northwestern University School of Medicine

Rebecca O’Connor, Director of Government Affairs, American Society for Reproductive Medicine (ASRM)

Torie Comeaux Plowden, MD, MPH, FACOG, IVF Director, Walter Reed National Military Medical Center

Gloria Salazar, MD, FSIR, Division Chief of Vascular and Interventional Radiology (VIR), University of North Carolina at Chapel Hill

Richard Shalansky-Goldberg, MD, Professor of Radiology and Obstetrics and Gynecology, University of Pennsylvania

Hugh Taylor, MD, Chair, Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine

Regina Townsend, Founder, The Broken Brown Egg

Sponsor